Literature DB >> 22231193

Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS.

Bianca Weinstock-Guttman1, Murali Ramanathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22231193     DOI： 10.1038/nrneurol.2011.213

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  6 in total

Review 1.  Cortical lesions in multiple sclerosis.

Authors:  Massimiliano Calabrese; Massimo Filippi; Paolo Gallo
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

2.  Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.

Authors:  Bianca Weinstock-Guttman; Robert Zivadinov; Murali Ramanathan
Journal:  J Neurol Sci       Date:  2011-08-16       Impact factor: 3.181

3.  Randomized trial of oral teriflunomide for relapsing multiple sclerosis.

Authors:  Paul O'Connor; Jerry S Wolinsky; Christian Confavreux; Giancarlo Comi; Ludwig Kappos; Tomas P Olsson; Hadj Benzerdjeb; Philippe Truffinet; Lin Wang; Aaron Miller; Mark S Freedman
Journal:  N Engl J Med       Date:  2011-10-06       Impact factor: 91.245

4.  A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.

Authors:  Ludwig Kappos; Ernst-Wilhelm Radue; Paul O'Connor; Chris Polman; Reinhard Hohlfeld; Peter Calabresi; Krzysztof Selmaj; Catherine Agoropoulou; Malgorzata Leyk; Lixin Zhang-Auberson; Pascale Burtin
Journal:  N Engl J Med       Date:  2010-01-20       Impact factor: 91.245

5.  Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies.

Authors:  Maria Pia Sormani; Massimiliano Calabrese; Alessio Signori; Antonio Giorgio; Paolo Gallo; Nicola De Stefano
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

6.  Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis.

Authors:  Bianca Weinstock-Guttman; Robert Zivadinov; Naeem Mahfooz; Ellen Carl; Allison Drake; Jaclyn Schneider; Barbara Teter; Sara Hussein; Bijal Mehta; Marc Weiskopf; Jacqueline Durfee; Niels Bergsland; Murali Ramanathan
Journal:  J Neuroinflammation       Date:  2011-10-04       Impact factor: 8.322
  6 in total
  4 in total

1.  Progenitor cell-based treatment of glial disease.

Authors:  Steven A Goldman
Journal:  Prog Brain Res       Date:  2017-04-13       Impact factor: 2.453

Review 2.  Glial progenitor cell-based treatment and modeling of neurological disease.

Authors:  Steven A Goldman; Maiken Nedergaard; Martha S Windrem
Journal:  Science       Date:  2012-10-26       Impact factor: 47.728

3.  Disruption of myelin leads to ectopic expression of K(V)1.1 channels with abnormal conductivity of optic nerve axons in a cuprizone-induced model of demyelination.

Authors:  Bandita Bagchi; Ahmed Al-Sabi; Seshu Kaza; Dimitri Scholz; Valerie B O'Leary; J Oliver Dolly; Saak V Ovsepian
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

Review 4.  Neurobehavioral burden of multiple sclerosis with nanotheranostics.

Authors:  Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-15       Impact factor: 2.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.